What's "Hidden" in the 21st Century Cures Act for Health Care Entities

by Nilan Johnson Lewis PA
Contact

The 21st Century Cures Act (Cures) was signed into law December 13, 2016. While the primary focus of the 996-page Act centered on biomedical innovation, several components of Cures have significant implications for health care entities outside of that context. The following are some lesser-known elements of Cures that could significantly affect the health care industry.

  1. Electronic health records system interoperability

Title 4 of Cures addresses enhancements to health care delivery. Section 4001 aims to reduce the documentation burden on health care providers, intending to ultimately enhance quality of care for patients. To do this, Cures encourages certification of health information technology (HIT) beyond the typical large hospital and clinic settings, such as certification of HIT for use at specialty providers and sites of service. The intent of the expansion of HIT certification is to ensure that more Electronic Health Records (EHR) meet the Center for Medicare and Medicaid Services’ (CMS) standards for improved quality, safety, and efficiency.

Section 4003 of Cures focuses on expediting interoperability among EHRs by developing or supporting a voluntary model framework and common agreement for the secure exchange of health information. Cures proposes to do this by creating a digital health care provider directory to facilitate this information exchange. Additionally, Cures requires the Department of Health and Human Services (HHS) to defer to HIT standards developed in the private sector, including creating a new HIT Advisory Committee to specifically address concerns around interoperability. The new HIT Advisory Committee is charged with engaging stakeholders to identify priorities for this standardization.

Cures also promotes developing and certifying patient-centered EHRs so that patients have better access to their health information in a secure and up-to-date manner. Under Section 4006, the Secretary of HHS must use his or her authority to encourage partnerships between health information exchange organizations, health care providers, and health plans with the goal of offering patient access to their electronic health information in a “single, longitudinal format that is easy to understand, secure, and may be updated automatically.” Section 4006 of Cures also adds a new element to the relationship between covered entities and business associates under the Health Insurance Portability and Accountability Act of 1996 (HIPAA), as amended by the Health Information Technology for Economic and Clinical Health (HITECH) Act. Specifically, Cures amends the HITECH Act to state that business associates may directly provide access to Protected Health Information (PHI) in response to a request from an individual. Due to this push to allow business associates to directly provide PHI to a patient in response to a request from that patient, health care entities may need to revisit their business associate agreements to ensure they are not unintentionally in conflict with this section of Cures.

  1. Further guidance on HIPAA surrounding mental health and substance abuse disorders

Title 11 of Cures is entitled “Compassionate Communication on HIPAA.” Under the sections of this title, Cures directs the Office of Civil Rights to issue new guidance to clarify when a health care provider or covered entity under HIPAA may use or disclose PHI specifically related to the treatment of an adult with a mental health or substance abuse disorder. This includes clarifying the parameters for sharing mental health and substance abuse information with close relatives. This title also requires HHS—with the help of stakeholders—to assess the impact of the recent, stricter updates to HIPAA governing the confidentiality of alcohol and drug abuse patient records under 42 CFR Part 2. While no specific changes to HIPAA were made as a result of this title, Congress’ directive alludes that future updates are impending.

  1. Updates to the Medicare hospital readmissions program

Titles 15, 16, and 17 of Cures amend certain portions of Medicare reimbursement regulations, including Medicare’s hospital readmission program. Section 15002 requires the Secretary of HHS to implement a transitional risk adjustment methodology to allow hospitals to account for patient backgrounds under the Hospital Readmissions Reduction Program (HRRP). Since the implementation of the Affordable Care Act (ACA), hospitals have traditionally been at-fault if a patient returns to the hospital within 30 days after discharge for the same reason that the patient originally was admitted. This is most notable for hospitals located in impoverished areas, where readmission rates can be higher as a result of a patient’s inability to afford medication, healthy food, or transportation to primary-care doctors. Cures now requires CMS to adjust penalties under HRRP based on the proportion of a hospital’s patients who are dual-eligible for Medicare and Medicaid. Dual-eligible patients are often expensive; they accounted for one third of total Medicare fee-for-service spending in 2012, while only comprising 18% of the total beneficiaries.

The Secretary of HHS is also authorized to construct a permanent risk-adjustment method for HRRP. However, Cures does not designate a specific framework beyond the Secretary needing to assign hospitals to groups based on its proportion of dual-eligible patients and apply “a methodology in a manner that allows for separate comparison of hospitals within each group.” Due to the difficulty in capturing which variables contribute most to risk of readmission, we can expect the HRRP risk-adjustment methodology to continue to evolve in the near future.

  1. Small employer health reimbursement arrangements

At the very end of Cures, Section 18001 amends the ACA and the Internal Revenue Code (IRC) to allow small employers, those with fewer than 50 employees, to establish health reimbursement arrangements (HRAs). Beginning on January 1, 2017, qualifying small employers can reimburse their employees up to $4,950 annually for employee-only coverage and $10,000 annually for family coverage, in lieu of providing employer-sponsored insurance. Other specific requirements apply, such as that an employee using this arrangement must show he or she actually buys health coverage, and an employer participating in the arrangement cannot use a salary reduction mechanism. HRAs were previously prohibited by the ACA and IRC for violating group health plan rules under these laws. Now that it is officially a permissible practice under the enumerated guidelines in Cures, such arrangements will likely become more widespread and increase enrollment in states’ individual health insurance markets as a result.


DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Nilan Johnson Lewis PA | Attorney Advertising

Written by:

Nilan Johnson Lewis PA
Contact
more
less

Nilan Johnson Lewis PA on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.